EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
EyePoint Pharmaceuticals beat estimated earnings by 3.45%, reporting an EPS of $-0.56 versus an estimate of $-0.58.
Revenue was up $1.97 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 1.15% increase in the share price the next day.
Here's a look at EyePoint Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.53 | -0.40 | -0.43 | -0.46 |
| EPS Actual | -0.59 | -0.58 | -0.42 | -0.50 |
| Revenue Estimate | 9.80M | 9.84M | 9.13M | 7.93M |
| Revenue Actual | 11.54M | 9.06M | 9.01M | 7.32M |
To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
